Literature DB >> 12971620

Role of cancer cell-stroma interaction in invasive growth of cancer cells.

Hiroaki Kataoka1, Hiroyuki Tanaka, Koki Nagaike, Shuichiro Uchiyama, Hiroshi Itoh.   

Abstract

Invasive growth is one of the hallmarks of cancer malignancy. To date, a significant body of evidence is accumulating in favor of the notion that invasive growth results from the cross-talk between cancer cells and the host stromal cells, comprising fibroblasts (myofibroblasts), endothelial cells, and leukocytes, all of which are themselves invasive. In this review we describe cross-talk between invasive cancer cells and host stromal fibroblasts and an impact of pericellular microenvironment on the invasive phenotype of cancer cells, focusing on two molecules, extracellular matrix metalloproteinase inducer (EMMPRIN, also known as tumor cell-derived collagenase stimulatory factor, basigin, CD147) and hepatocyte growth factor (HGF, also known as scatter factor). Both molecules are deeply involved in the regulation of invasion-associated cellular activities, such as pericellular proteolysis, migration and ectopic survival of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12971620     DOI: 10.1111/j.1749-0774.2003.tb00123.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.374


  88 in total

Review 1.  Scatter-factor and semaphorin receptors: cell signalling for invasive growth.

Authors:  Livio Trusolino; Paolo M Comoglio
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

2.  Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor.

Authors:  T Kawaguchi; L Qin; T Shimomura; J Kondo; K Matsumoto; K Denda; N Kitamura
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

3.  Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.

Authors:  R Abounader; S Ranganathan; B Lal; K Fielding; A Book; H Dietz; P Burger; J Laterra
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

4.  Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk.

Authors:  C Y Lin; J Anders; M Johnson; R B Dickson
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

5.  Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro.

Authors:  J van Adelsberg; S Sehgal; A Kukes; C Brady; J Barasch; J Yang; Y Huan
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

6.  Mouse hepatocyte growth factor activator gene: its expression not only in the liver but also in the gastrointestinal tract.

Authors:  H Itoh; R Hamasuna; H Kataoka; M Yamauchi; K Miyazawa; N Kitamura; M Koono
Journal:  Biochim Biophys Acta       Date:  2000-04-25

7.  Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway.

Authors:  Paul M Taylor; Richard J Woodfield; Matthew N Hodgkin; Trevor R Pettitt; Ashley Martin; David J Kerr; Michael J O Wakelam
Journal:  Oncogene       Date:  2002-08-22       Impact factor: 9.867

8.  Activation of the zymogen of hepatocyte growth factor activator by thrombin.

Authors:  T Shimomura; J Kondo; M Ochiai; D Naka; K Miyazawa; Y Morimoto; N Kitamura
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

9.  Hepatocyte growth factor activator: a possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract.

Authors:  Y Matsubara; M Ichinose; N Yahagi; S Tsukada; M Oka; K Miki; S Kimura; M Omata; K Shiokawa; N Kitamura; Y Kaneko; H Fukamachi
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

10.  Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.

Authors:  E Gohda; H Tsubouchi; H Nakayama; S Hirono; O Sakiyama; K Takahashi; H Miyazaki; S Hashimoto; Y Daikuhara
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

View more
  13 in total

1.  Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.

Authors:  Yutaka Akiyama; Miyuki Nagai; Wataru Komaki; Kousuke Marutsuka; Yujiro Asada; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2006-08       Impact factor: 4.174

Review 2.  Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.

Authors:  E M V de Cuba; R Kwakman; M van Egmond; L J W Bosch; H J Bonjer; G A Meijer; E A te Velde
Journal:  Virchows Arch       Date:  2012-07-24       Impact factor: 4.064

3.  Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus.

Authors:  Sebastian F Schoppmann; Bettina Jesch; Martin F Riegler; Florian Maroske; Katrin Schwameis; Gerd Jomrich; Peter Birner
Journal:  Clin Exp Metastasis       Date:  2012-11-19       Impact factor: 5.150

4.  Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.

Authors:  Eric E Gabison; Samia Mourah; Emanuelle Steinfels; Li Yan; Thanh Hoang-Xuan; Mitchel A Watsky; Bart De Wever; Fabien Calvo; Alain Mauviel; Suzanne Menashi
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

Review 5.  Imaging and quantifying the dynamics of tumor-associated proteolysis.

Authors:  Mansoureh Sameni; Dora Cavallo-Medved; Julie Dosescu; Christopher Jedeszko; Kamiar Moin; Stefanie R Mullins; Mary B Olive; Deborah Rudy; Bonnie F Sloane
Journal:  Clin Exp Metastasis       Date:  2008-12-13       Impact factor: 5.150

6.  Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.

Authors:  Yue-Hu Han; Bo Gao; Jing-Hui Huang; Zhen Wang; Zheng Guo; Qiang Jie; Liu Yang; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

7.  Catalytically inactive human cathepsin D triggers fibroblast invasive growth.

Authors:  Valérie Laurent-Matha; Sharon Maruani-Herrmann; Christine Prébois; Mélanie Beaujouin; Murielle Glondu; Agnès Noël; Marie Luz Alvarez-Gonzalez; Sylvia Blacher; Peter Coopman; Stephen Baghdiguian; Christine Gilles; Jadranka Loncarek; Gilles Freiss; Françoise Vignon; Emmanuelle Liaudet-Coopman
Journal:  J Cell Biol       Date:  2005-01-24       Impact factor: 10.539

8.  Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.

Authors:  Sophie Vasseur; Cédric Malicet; Ezequiel L Calvo; Jean Charles Dagorn; Juan L Iovanna
Journal:  Mol Cancer       Date:  2005-01-16       Impact factor: 27.401

9.  Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell line.

Authors:  Esteban N Gurzov; Sanaa M Nabha; Hamilto Yamamoto; Hong Meng; O Graciela Scharovsky; R Daniel Bonfil
Journal:  BMC Cancer       Date:  2007-10-01       Impact factor: 4.430

Review 10.  Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum.

Authors:  Lieselotte Lemoine; Paul Sugarbaker; Kurt Van der Speeten
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.